A TRANSDUCER OF MAS SIGNALLING

Details for Australian Patent Application No. 2003203145 (hide)

Owner NOVO NORDISK A/S

Inventors STENNICKE, Vibeke, Westphal; GRONDAHL, Christian; WAHL, Philip; NORBY, Peder, Lisby

Pub. Number AU-A-2003203145

PCT Number PCT/DK03/00058

PCT Pub. Number WO2003/070766

Priority PA 2002 00277 22.02.02 DK

Filing date 31 January 2003

Wipo publication date 9 September 2003

International Classifications

C07K 014/705 Peptides having more than 20 amino acids

A61K 031/575 - substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C12N 015/12 Mutation or genetic engineering - Genes encoding animal proteins

C07J 009/00 Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Event Publications

10 April 2003 Complete Application Filed

  Priority application(s): PA 2002 00277 22.02.02 DK

9 October 2003 Application Open to Public Inspection

  Published as AU-A-2003203145

11 November 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003203146-USE OF GLP-1 COMPOUND FOR TREATMENT OF CRITICALLY ILL PATIENTS

2003203144-COMPOSITIONS AND METHODS FOR MODULATING CONNEXIN HEMICHANNELS